Outlook Therapeutics- Warrants Profit Margin

As of the most recent data (June 2026), OTLKW shows a profit margin of -49776.98%. That compares with -8270.57% in the prior-year period — down 501.9% year over year. That is below the Healthcare sector average of 13.71%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OTLKW's profit margin is now -49776.98% (was -8270.57%) — a 501.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Outlook Therapeutics- Warrants is outperforming or lagging.

The Healthcare sector average profit margin is about 13.71%. Outlook Therapeutics- Warrants is at -49776.98%, which is lower that average. That is roughly 363148.3% below the sector mean. Use the comparison chart on this page to see how OTLKW stacks up against individual peers as well.

That compares with -8270.57% in the prior-year period — down 501.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Outlook Therapeutics- Warrants with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Outlook Therapeutics- Warrants's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -49776.98%) with ownership activity and broader fundamentals.